WEE1 and ovarian carcinoma: Consistent with its role of WEE1i in cell fate and cisplatin resistance probably, a higher levels of wee1 correlate with a poor relapse-free survival stratified from a large public clinical microarray database of ovarian cancer patients undergone chemotherapy, which contained cisplatin, as well as breast tumor patients undergone chemotherapy (Fig. 7d,e)36, 37.